• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2961161
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
36.34
36698.43
EPS(TTM)
Face Value()
Div & Yield %
59.61
10
2.63
 

As on: Jun 05, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,166.30 -0.20 2381 36.34
Stock Price Details
Open Price() 2,166.50
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,184.95
Today's Low () 2,160.50
52-Week High () 3515.95
152-Week Low () 2155
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 2.63
Eps 59.61
Book Value 132.2961161
Market Cap (.Cr) 36,698.43
Face Value 10
Market Lot 1
AGM Date Jun
Book Closure Date
ISIN No. INE159A01016


News
GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
GlaxoSmithKline Pharmaceuticals to hold AGM
Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
GSK Pharma Q4 PAT rises 6% YoY to Rs 275 cr
GlaxoSmithKline Pharmaceuticals to announce Quarterly Result
Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncology
Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
GlaxoSmithKline Pharmaceuticals to table results
More
Corporate Details
Incoporation Year   : 1924
Chairman : Renu S Karnad
Bussiness Group : MNC Asc-Glaxo
Registered Office
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-022-24959595
Fax:91-022-24959494
Fax:91-22-66317458
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi